This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Stocks Reports for McDonald's, AbbVie & Altria
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), AbbVie (ABBV) and Altria (MO).
4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
by Sanghamitra Saha
These are the factors that could send marijuana stocks and ETF high in 2019.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $53.95, moving +1.11% from the previous trading session.
Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
by Ryan McQueeney
Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
Cronos Group (CRON) Soars on C$2.4B Investment from Altria
by Zacks Equity Research
Cronos Group (CRON) receives a significant boost with C$2.4-billion equity investment from tobacco giant Altria Group.
Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?
by Sweta Killa
Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?
Company News For Dec 10, 2018
by Zacks Equity Research
Companies In The News Are: BIG,ULTA,CRON,MO,LULU
Tobacco Industry Outlook: RRPs Could Drive Recovery
by Zacks Equity Research
Stringent FDA regulations have led to fading cigarette sales, plaguing the performance of most tobacco stocks. Nevertheless, reduced risk products are viewed as a viable growth platform.
Company News For Dec 5, 2018
by Zacks Equity Research
Companies In The News Are: DG,AZO,RH,CRON,MO
Why Tesla Is a Buy-Ranked Stock & the Latest Cannabis Industry Buzz
by Ryan McQueeney
Ryan McQueeney discusses President Trump's "Tariff Man" tweets and recaps the latest news from the cannabis industry. Later, he chats with Brian Bolan about Tesla (TSLA), a Zacks Rank #1 (Strong Buy) stock.
Why Cannabis Stocks CRON & APHA Are Moving in Opposite Directions
by Ryan McQueeney
Shares of Cronos Group (CRON) and Aphria (APHA) extended their recent moves in opposite directions on Tuesday morning, as investors continued to digest major headlines related to the popular cannabis companies.
Altria Likely to Venture Into Cannabis Space With Cronos Deal
by Zacks Equity Research
Per sources, Altria (MO) is likely to explore opportunities in the cannabis space through a deal with Cronos.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $55.73, marking a +1.64% move from the previous day.
Altria-Juul Tie-Up News Puts Consumer Staple ETFs in Focus
by Zacks Equity Research
Altria is in talks with e-cigarette maker Juul for acquiring a minority stake, putting consumer staple ETFs in focus.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $56.77 in the latest trading session, marking a -0.89% move from the prior day.
Juul Burns Out: Company Ends Sales & Social Media Promotions
by Nimah Quadri
It was a long time coming, but the $15 billion startup that had 70% market share of the e-cig industry has faced the consequences.
The Zacks Analyst Blog Highlights: Altria, American Express, U.S. Bancorp, T-Mobile and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, American Express, U.S. Bancorp, T-Mobile and Humana
Top Stock Reports for Altria, American Express & U.S. Bancorp
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Altria (MO), American Express (AXP) and U.S. Bancorp (USB).
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $64.63, marking a +1.51% move from the previous day.
ECigarette Company Juul Labs is Now Worth $15 Billion
by Madeleine Johnson
Juul is a booming e-cigarette company thanks to its popularity with teens and young adults.
Altria (MO) Q3 Earnings Top, Revenues Gain on Strong Pricing
by Zacks Equity Research
Altria's (MO) Q3 performance reflects consistent gains from higher pricing in the smokeable and smokeless segments.
Altria (MO) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 0.93% and 1.43%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Pricing & Smokeless Unit Aid Altria's (MO) Q3 Earnings?
by Zacks Equity Research
Altria's (MO) Q3 performance to gain from strong pricing and strength in low risk alternatives. However, declining cigarette volumes is a concern.
Altria (MO) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.